By Emily Carter, March 10, 2026

Intravitreal Eye Injections

Intravitreal eye injections have emerged as a vital therapeutic option in the management of various retinal diseases, both chronic and acute. This procedure involves the injection of medication directly into the vitreous cavity of the eye, enabling localized drug delivery. For patients suffering from conditions such as diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion, these interventions can significantly alter the disease trajectory and improve visual outcomes.

The Importance of Intravitreal Injections

The incidence of retinal diseases continues to rise, largely due to an aging population and increasing prevalence of diabetes. As we delve into the intricacies of intravitreal eye injections, it is important to understand their role in preserving vision and enhancing the quality of life. By administering medications directly into the vitreous humor, clinicians can achieve therapeutic levels at the site of action while minimizing systemic exposure and potential side effects.

Indications for Intravitreal Injections

Intravitreal injections are indicated for a variety of ocular conditions, each with its unique pathophysiology and treatment goals. Common indications include:

• Age-Related Macular Degeneration (AMD): The most common cause of severe vision loss in individuals over 50, AMD manifests as central vision deterioration. Anti-VEGF (vascular endothelial growth factor) agents administered via intravitreal injection can slow the progression of wet AMD.
• Diabetic Retinopathy: A complication of diabetes affecting the retina, leading to potential vision loss. Medications such as steroids or anti-VEGF agents can stabilize or improve vision when delivered through intravitreal injection.
• Retinal Vein Occlusion: This condition, resulting from blockage in the retinal veins, often leads to edema and hemorrhage. Intravitreal injections can alleviate these symptoms and improve visual function.
• Uveitis: This inflammation of the middle layer of the eye often requires corticosteroids or immunosuppressive therapies that may be more effective when injected intravitreally.

The Procedure: What Patients Can Expect

Understanding the intravitreal injection procedure can alleviate patient anxiety and ensure a more positive experience. The process typically follows these steps:

1. Preparation: Before the procedure, the eye is numbed using topical anesthetic drops. Patients may also receive additional measures to reduce anxiety, such as counseling or verbal reassurance.
2. Injection: Under sterile conditions, the ophthalmologist uses a fine needle to inject the medication into the vitreous body. The procedure is quick and usually lasts less than 30 minutes.
3. Post-Injection Care: After the injection, patients are monitored for a short period to observe for any immediate reactions. They typically can return to normal activities shortly thereafter, with specific follow-up instructions provided by the clinician.

Potential Risks and Complications

While intravitreal injections are generally safe, they are not without risks. Common complications can include:

• Infection (Endophthalmitis): Although rare, this serious eye infection can occur following injection.
• Retinal Detachment: A separation of the retina from its underlying tissue can lead to vision loss if not treated swiftly.
• Hemorrhage: Bleeding into the eye can occur, leading to diminished vision.